Roquefort Investments PLC
Roquefort Therapeutics plc, a material biotech company, engages in the development of medicines for the treatment of cancer. Its product portfolio consists of five novel patent-protected pre-clinical anti-cancer medicines, which include Midkine antibodies with significance in vivo efficacy and toxicology studies, as well as orphan drug indication; Midkine RNA oligonucleotide therapeutics with nov… Read more
Market Cap & Net Worth: Roquefort Investments PLC (ROQ)
Roquefort Investments PLC (LSE:ROQ) has a market capitalization of $20.42K (GBX167.82 Million) as of March 18, 2026. Listed on the LSE stock exchange, this UK-based company holds position #49670 globally and #1397 in its home market, demonstrating a 2.50% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Roquefort Investments PLC's stock price GBX1.03 by its total outstanding shares 163726294 (163.73 Million).
Roquefort Investments PLC Market Cap History: 2021 to 2026
Roquefort Investments PLC's market capitalization history from 2021 to 2026. Data shows change from $209.17K to $20.42K (-31.46% CAGR).
Roquefort Investments PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Roquefort Investments PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.72x
Roquefort Investments PLC's market cap is 0.72 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $209.17K | $719.00 | -$917.43K | 290.92x | N/A |
| 2023 | $144.43K | $200.00K | -$1.74 Million | 0.72x | N/A |
Competitor Companies of ROQ by Market Capitalization
Companies near Roquefort Investments PLC in the global market cap rankings as of March 18, 2026.
Key companies related to Roquefort Investments PLC by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Roquefort Investments PLC Historical Marketcap From 2021 to 2026
Between 2021 and today, Roquefort Investments PLC's market cap moved from $209.17K to $ 20.42K, with a yearly change of -31.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX20.42K | -18.00% |
| 2025 | GBX24.90K | -69.14% |
| 2024 | GBX80.68K | -44.14% |
| 2023 | GBX144.43K | +9.43% |
| 2022 | GBX131.98K | -36.90% |
| 2021 | GBX209.17K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Roquefort Investments PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.42K USD |
| MoneyControl | $20.42K USD |
| MarketWatch | $20.42K USD |
| marketcap.company | $20.42K USD |
| Reuters | $20.42K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.